David R. Head

11.9k total citations · 5 hit papers
90 papers, 8.8k citations indexed

About

David R. Head is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, David R. Head has authored 90 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 28 papers in Public Health, Environmental and Occupational Health and 22 papers in Molecular Biology. Recurrent topics in David R. Head's work include Acute Myeloid Leukemia Research (52 papers), Acute Lymphoblastic Leukemia research (28 papers) and Retinoids in leukemia and cellular processes (13 papers). David R. Head is often cited by papers focused on Acute Myeloid Leukemia Research (52 papers), Acute Lymphoblastic Leukemia research (28 papers) and Retinoids in leukemia and cellular processes (13 papers). David R. Head collaborates with scholars based in United States, Canada and Singapore. David R. Head's co-authors include Frederick R. Appelbaum, Cheryl L. Willman, Marilyn L. Slovak, Kenneth J. Kopecky, John E. Godwin, Peter A. Cassileth, Catherine P. Leith, Jacob M. Rowe, Susana C. Raimondi and Stephen H. Petersdorf and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

David R. Head

89 papers receiving 8.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

2000 1.2k citations Marilyn L. Slovak, Kenneth J. Kopecky et al. Blood profile →
Age and acute myeloid leukemia

2006 982 citations Frederick R. Appelbaum, David R. Head et al. Blood profile →
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

1997 696 citations Catherine P. Leith, Kenneth J. Kopecky et al. Blood profile →
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

1990 617 citations Bruce D. Cheson, Peter A. Cassileth et al. Journal of Clinical Oncology profile →
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

1991 523 citations Ching‐Hon Pui, Susana C. Raimondi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David R. Head United States	35	6.5k	3.2k	3.1k	2.0k	1.5k	90	8.8k
Miloslav Beran United States	46	5.2k 0.8×	2.2k 0.7×	2.3k 0.7×	1.8k 0.9×	3.4k 2.3×	106	8.5k
Peter L. Greenberg United States	45	9.1k 1.4×	3.2k 1.0×	1.4k 0.5×	1.7k 0.8×	3.8k 2.6×	203	11.0k
Anthony V. Moorman United Kingdom	51	7.1k 1.1×	2.6k 0.8×	6.5k 2.1×	1.7k 0.8×	1.4k 1.0×	183	10.2k
Tapan M. Kadia United States	57	9.8k 1.5×	5.4k 1.7×	3.0k 1.0×	2.7k 1.3×	3.9k 2.7×	778	13.2k
Steven D. Gore United States	44	6.2k 1.0×	3.6k 1.1×	1.4k 0.4×	1.2k 0.6×	2.1k 1.4×	226	8.1k
Nigel H. Russell United Kingdom	57	8.9k 1.4×	4.4k 1.4×	2.5k 0.8×	3.3k 1.6×	2.5k 1.7×	355	12.4k
Joseph O. Moore United States	42	3.3k 0.5×	1.8k 0.6×	1.2k 0.4×	1.9k 0.9×	1.5k 1.0×	148	6.6k
C. Sultan France	19	8.8k 1.3×	2.8k 0.9×	2.8k 0.9×	1.2k 0.6×	3.1k 2.1×	29	10.6k
Aristoteles Giagounidis Germany	49	8.5k 1.3×	3.4k 1.1×	1.5k 0.5×	1.2k 0.6×	3.7k 2.5×	259	10.3k
Anjali S. Advani United States	41	3.5k 0.5×	1.6k 0.5×	3.0k 1.0×	2.9k 1.4×	1.2k 0.8×	298	7.1k

Countries citing papers authored by David R. Head

Since Specialization

Citations

This map shows the geographic impact of David R. Head's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Head with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Head more than expected).

Fields of papers citing papers by David R. Head

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Head. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Head. The network helps show where David R. Head may publish in the future.

Co-authorship network of co-authors of David R. Head

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Head. A scholar is included among the top collaborators of David R. Head based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Head. David R. Head is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taub, Jeffrey W., Todd A. Alonzo, Alan S. Gamis, et al.. (2019). Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431. Archives of Pathology & Laboratory Medicine. 144(4). 466–472. 9 indexed citations

Strickland, Stephen A., Aaron C. Shaver, Michael Byrne, et al.. (2018). Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. Leukemia Research. 65. 67–73. 10 indexed citations

Briggs, Robert C., Keith Shults, Madan Jagasia, et al.. (2006). Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis. Cancer Research. 66(9). 4645–4651. 36 indexed citations

Xie, Jingping, et al.. (2005). Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter‐strand crosslinking nitrogen mustard, mechlorethamine. Journal of Cellular Biochemistry. 95(2). 339–351. 16 indexed citations

Leith, Catherine P., Kenneth J. Kopecky, I‐Ming Chen, et al.. (1999). Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.. Blood. 94(3). 1086–99. 479 indexed citations

Leach, Charles T., Christopher Frantz, David R. Head, et al.. (1999). Human herpesvirus-8 (HHV-8) associated with small non-cleaved cell lymphoma in a child with AIDS. American Journal of Hematology. 60(3). 215–221. 11 indexed citations

Chan, Gcf, David R. Head, & Winfred C. Wang. (1999). Refractory Anemia With Ringed Sideroblasts in Children. Journal of Pediatric Hematology/Oncology. 21(5). 418–423. 2 indexed citations

Kuefer, Martin U., Winfred C. Wang, David R. Head, et al.. (1998). Thrombopoietin Level in Young Patients Is Related to Megakaryocyte Frequency and Platelet Count. Journal of Pediatric Hematology/Oncology. 20(1). 36–43. 11 indexed citations

Broniscer, Alberto, R. C. Ribeiro, R V Srinivas, et al.. (1996). An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine.. PubMed. 10(7). 1244–8. 5 indexed citations

10.

Behm, Fred G., Ching‐Hon Pui, Guillermo O. Rangel Rivera, et al.. (1995). Acute lymphoblastic leukemias expressing NK cell-associated CD56 do not arise from NK cell progenitors. Modern Pathology. 8(1). 106. 1 indexed citations

11.

Wang, Winfred C., et al.. (1995). Magnetic Resonance Imaging for Evaluation of Childhood Aplastic Anemia. Journal of Pediatric Hematology/Oncology. 17(4). 284–289. 3 indexed citations

12.

Head, David R.. (1995). Atlas of Tumor Pathology: Tumors of the Bone Marrow. American Journal of Clinical Pathology. 103(2). 253.1–253. 20 indexed citations

13.

Slovak, Marilyn L., S. Thomas Traweek, Cheryl L. Willman, et al.. (1995). Trisomy 11: an association with stem/progenitor cell immunophenotype. British Journal of Haematology. 90(2). 266–273. 34 indexed citations

14.

Miller, K B, Francis S. Morrison, Jane N. Winter, et al.. (1993). The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Annals of Hematology. 66(3). 164–164. 91 indexed citations

15.

Downing, JR, et al.. (1993). Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.. PubMed. 143(5). 1294–300. 128 indexed citations

16.

Elias, Laurence, Donna Stock-Novack, David R. Head, et al.. (1993). A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.. PubMed. 7(3). 361–5. 55 indexed citations

17.

Head, David R. & James R. Downing. (1992). Pathology and immunology of leukemia. Current Opinion in Oncology. 4(1). 14–23. 3 indexed citations

18.

Thompson, Elizabeth, Judith A. Wilimas, Laura C. Bowman, et al.. (1990). Myeloid neoplasia in children treated for solid tumours. The Lancet. 336(8712). 417–421. 85 indexed citations

19.

Cheson, Bruce D., Peter A. Cassileth, David R. Head, et al.. (1990). Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.. Journal of Clinical Oncology. 8(5). 813–819. 617 indexed citations breakdown →

20.

Marmer, Daniel J., et al.. (1980). Von willebrand factor (VIII_VWF) in lyophilized factor VIII concentrates. American Journal of Hematology. 9(1). 39–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact